This report provides an in-depth analysis of one of the most pressing issues facing the global pharmaceutical industry today -- its reputation and how it deals with perceptions about its business and operational models.
This report (along with the first in the series Integrity driven performance in the pharmaceutical industry) was co-developed by the pharmaceutical industry group and the firm's Health Research Institute.
Publications Search Page
